Glazer Capital LLC’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Glazer Capital LLC’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-307,532	Closed	-$3.33M	–	209
2023 Q3	$3.33M	Sell	307,532 -588	-0.2%	-$6.31K	0.22%	77
2023 Q2	$3.28M	Buy	308,120 +151,707	+97%	+$1.6M	0.22%	92
2023 Q1	$1.63M	Sell	156,413 -11,502	-7%	-$119K	0.09%	177
2022 Q4	$1.72M	Buy	167,915 +14,448	+9%	+$147K	0.04%	239
2022 Q3	$1.54M	Sell	153,467 -591	-0.4%	-$5.91K	0.03%	332
2022 Q2	$1.54M	Buy	154,058 +36,382	+31%	+$361K	0.04%	348
2022 Q1	$1.16M	Buy	+117,676	New	+$1.16M	0.03%	301

Glazer Capital LLC's BIOS Position: Q4 2023 in Review

Glazer Capital LLC sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2023, closing a stake of 307,532 shares — an estimated $3.33M sold.

Glazer Capital LLC first reported a position in BIOS in Q1 2022 and held it in 7 quarters. The position peaked at $3.33M in Q3 2023. 0 funds tracked by Wall St. Rank hold BIOS as of Q4 2023.

Glazer Capital LLC reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Glazer Capital LLC sold 307,532 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $3.33M.
Glazer Capital LLC first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 7 quarters.
Glazer Capital LLC's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $3.33M in Q3 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on Glazer Capital LLC's 13F filing for Q4 2023, filed 14 Feb 2024.